ClinVar Miner

Submissions for variant NM_206933.4(USH2A):c.9860_9873del (p.His3287fs)

dbSNP: rs1388040238
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001383885 SCV001583204 pathogenic not provided 2023-11-18 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.His3287Profs*54) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is present in population databases (no rsID available, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with Usher syndrome (PMID: 28041643). ClinVar contains an entry for this variant (Variation ID: 438035). For these reasons, this variant has been classified as Pathogenic.
Fulgent Genetics, Fulgent Genetics RCV002496963 SCV002810918 likely pathogenic Usher syndrome type 2A; Retinitis pigmentosa 39 2022-02-04 criteria provided, single submitter clinical testing
SN ONGC Dept of Genetics and Molecular biology Vision Research Foundation RCV000504990 SCV003927119 pathogenic Usher syndrome 2022-12-31 criteria provided, single submitter research
Neuberg Centre For Genomic Medicine, NCGM RCV001829439 SCV004100575 pathogenic Usher syndrome type 2A criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV003449430 SCV004182641 likely pathogenic Retinitis pigmentosa 39 2023-11-04 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001829439 SCV004182643 likely pathogenic Usher syndrome type 2A 2023-11-04 criteria provided, single submitter clinical testing
Baylor Genetics RCV003449430 SCV004206450 pathogenic Retinitis pigmentosa 39 2024-02-29 criteria provided, single submitter clinical testing
NIHR Bioresource Rare Diseases, University of Cambridge RCV000504834 SCV000598844 uncertain significance Retinitis pigmentosa 2015-01-01 no assertion criteria provided research
NIHR Bioresource Rare Diseases, University of Cambridge RCV000504990 SCV000598845 uncertain significance Usher syndrome 2015-01-01 no assertion criteria provided research
Natera, Inc. RCV001829439 SCV002088381 pathogenic Usher syndrome type 2A 2021-04-15 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.